阅读说明：本技术 用于运动机能亢进性运动障碍的治疗的vmat2抑制剂 (VMAT2 inhibitors for the treatment of hyperkinetic movement disorders ) 是由 克里斯托弗·F·奥布赖恩 于 2015-05-06 设计创作，主要内容包括：提供治疗运动机能亢进性疾病和病症,如迟发性运动障碍的方法。在某一实施方案中,将有效的VMAT2抑制剂(+)α-3-异丁基-9,10-二甲氧基-1,3,4,6,7,11b-六氢-2H-吡啶并[2,1-a]异喹啉-2-醇((+)α-HTBZ)用于本文所述的方法,以对需要治疗的患者进行治疗。(Methods for treating hyperkinetic diseases and disorders, such as tardive dyskinesia, are provided. In a certain embodiment, the potent VMAT2 inhibitor (+) α -3-isobutyl-9, 10-dimethoxy-1, 3,4,6,7,11 b-hexahydro-2H-pyrido [2,1-a ] isoquinolin-2-ol ((+) α -HTBZ) is used in the methods described herein for the treatment of a patient in need thereof.)